Silver Nanoparticle-Incorporated Hydroxyapatite-Chitosan-PVP-Based Scaffold for Bone Tissue Engineering: Physicochemical Characterization, Antibacterial Activity, and In Vitro Ceftriaxone Release Study
Advances in Materials Science and Engineering · 30.10.2023 · 2023 · 1-14
DOI: 10.1155/2023/9234962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Materials Science and Engineering, erschienen am 30.10.2023. Verfasst von Polash Chandra Karmakar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Government of the People’s Republic of Bangladesh.
Abstract (Originalsprache)
The development of biocompatible scaffolds is rapidly growing in several fields of human health, particularly for the treatment of bone defects. In this study, silver nanoparticle (AgNPs)-incorporated hydroxyapatite (HA), chitosan (Chi), and polyvinylpyrrolidone (PVP)-based scaffolds were fabricated using the freeze-drying method for bone tissue engineering. Physicochemical properties such as porosity, density, swelling ratio, and biodegradability, as well as blood biocompatibility, brine shrimp lethality, antibacterial activities, FTIR-ATR, tensile strength, cytotoxicity, and SEM, were conducted. A study on the in vitro release of ceftriaxone (Cef), a routinely prescribed medication for treating osteomyelitis, was done. The selected scaffolds had desirable porosity, density, swelling capability, and biodegradation rate, which would meet the basic prerequisites for osteogenesis. The scaffolds showed qualitative and quantitative antibacterial activities against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Scaffolds were minimally cytotoxic to brine shrimp and RBC biocompatible. FTIR analysis confirmed intermolecular interaction among components of scaffolds. Scaffold had a tensile strength of 2.9 ± 0.22 N/mm2 and a non-cytotoxic effect on Vero cell lines. Surface morphology, pore shape, and sizes (98–382 μm) were observed through SEM. The percentage of drug (Cef) loading was found to be 63.16 ± 4.85%. An initial burst release of Cef was 40.21 ± 1.50% in the first 24 h. A sustained release of Cef was observed after 4 days, and about 60.36 ± 2.38% was released within 14 days. Therefore, selected AgNPs-incorporated HA-Chi-PVP scaffold could be a potential aid for bone tissue engineering.
Förderung
- Ministry of Science and Technology, Government of the People’s Republic of Bangladesh
Zitieren
APA
Karmakar, P. C., Chamely, M. I., -Al-Arafat, T., Khatun, M., Akhtar, N., & Asaduzzaman, S. M. (2023). Silver Nanoparticle-Incorporated Hydroxyapatite-Chitosan-PVP-Based Scaffold for Bone Tissue Engineering: Physicochemical Characterization, Antibacterial Activity, and In Vitro Ceftriaxone Release Study. Advances in Materials Science and Engineering, 2023, 1-14. https://doi.org/10.1155/2023/9234962
Vancouver
Karmakar PC, Chamely MI, -Al-Arafat T, Khatun M, Akhtar N, Asaduzzaman SM. Silver Nanoparticle-Incorporated Hydroxyapatite-Chitosan-PVP-Based Scaffold for Bone Tissue Engineering: Physicochemical Characterization, Antibacterial Activity, and In Vitro Ceftriaxone Release Study. Advances in Materials Science and Engineering. 2023;2023:1-14. doi:10.1155/2023/9234962
BibTeX
@article{Karmakar2023,
author = {Karmakar, Polash Chandra and Chamely, Monira Islam and -Al-Arafat, Tusher and Khatun, Marina and Akhtar, Naznin and Asaduzzaman, S. M.},
title = {Silver Nanoparticle-Incorporated Hydroxyapatite-Chitosan-PVP-Based Scaffold for Bone Tissue Engineering: Physicochemical Characterization, Antibacterial Activity, and In Vitro Ceftriaxone Release Study},
journal = {Advances in Materials Science and Engineering},
year = {2023},
volume = {2023},
pages = {1--14},
doi = {10.1155/2023/9234962}
}
EUVIMED